AMR-Lung
@Amr_Lung
A European Respiratory Society Clinical Research Collaboration to develop a better understanding of AMR in respiratory disease.
Ollie Pitts presenting our work showing the feasibility of international AMR mapping and the rising prevalence of AMR globally #ERSCongress AMR-Lung is now developing an international prospective registry of AMR- we are open to collaboration ([email protected])

Original research just published from our CRC! AMR is prevalent in chronic lung disease globally Challenges in fighting AMR vary between different geographical regions Look out for more exciting research from our CRC in the future aricjournal.biomedcentral.com/articles/10.11…
Just published: our open-access paper showing results of a global survey of healthcare worker views on antimicrobial resistance in lung disease Pleased to help lead this research with @drAnand_Shah_ on behalf of the @EuroRespSoc @Amr_Lung CRC aricjournal.biomedcentral.com/articles/10.11…
Read the @LancetRespirMed editorial on the global antimicrobial resistance crisis thelancet.com/journals/lanre…
🚀 Thrilled to announce our work on bronchiectasis epidemiology is out! Huge thanks to co-authors Irena Laska, Letizia Traversi, @edo_simonetta, @EvaPolverino, and editors @ProfJDChalmers, Dr Goeminne, and Dr Ringshausen. Check it out: err.ersjournals.com/content/errev/… @ERSpublications 🎉
There could be over 8 million deaths associated with antimicrobial resistance globally by 2050- with people over 70 mostly affected Urgent action is needed to address #AMR thelancet.com/journals/lance…
The fantastic @Amr_Lung team are looking for more global sites to join their registry on antimicrobial resistance. This is a really important topic in lung disease, and a @EuroRespSoc initiative. Check out their page for details, and please consider joining or sharing. 🦠🫁
Many thank @ProfHurst Do get in touch if interested in taking part in our prospective AMR registry in chronic lung disease. Either DM or email [email protected] for more details #AMR #Lung @EuroRespSoc
The fantastic @Amr_Lung team are looking for more global sites to join their registry on antimicrobial resistance. This is a really important topic in lung disease, and a @EuroRespSoc initiative. Check out their page for details, and please consider joining or sharing. 🦠🫁
Pleasure to present our global survey of healthcare worker views on antimicrobial resistance in chronic lung disease. This will lead to many more exciting projects from @Amr_Lung #ERSCongress
@DrSachinAnanth presenting healthcare views on #AMR in chronic #lung disease @EuroRespSoc #ERS2024 Huge burden and challenges with geographic variation
A fantastic session this afternoon with the AMR-Lung CRC team followed by an excellent dinner in beautiful Vienna! Lots of great ideas about where we direct our energies to understand and fight antimicrobial resistance! @EuropeanLung @EuroRespSoc #antimicrobialresistance

Also latest interim data from retrospective #AMR prevalence study. 9 centres, 6 countries, >10000 pts! Exciting data presented at Poster PS-23 on Tuesday highlighting prevalence of species specific AMR data #ERSCongress2024 Come visit and learn about ongoing work!
Looking forward to #ERSCongress2024 Highlights from the @Amr_Lung CRC @DrSachinAnanth presenting respiratory healthcare worker views on #AMR from 60 countries on Tuesday afternoon
85 ERS Clinical Research Collaboration (CRC) abstracts will be showcased at this year’s ERS Congress. @Amr_Lung will present ‘Healthcare worker views on antimicrobial resistance in chronic respiratory disease’. Find out more about the session: k4.ersnet.org/prod/v2/Front/…
On #WorldBronchiectasisDay, check out really interesting research about the bronchiectasis "resistome" (diverse pool of antimicrobial resistance genes) @mmacaogain @ProfJDChalmers atsjournals.org/doi/10.1164/rc…

Please help us and complete this survey esp. in #Hindi and #Telugu as part of @Amr_Lung in partnership with @EuropeanLung to improve our understanding of how #AMR affects individuals with chronic #lung conditions like #asthma #bronchiectasis #copd in #India #MedTwitter #MedX
Do you have a chronic lung condition? Take this survey to let us know your experience and understanding of antimicrobial resistance to help us to tackle it in the future. The survey takes about 15 minutes and is available in 20 languages. Find out more: europeanlung.org/en/get-involve…
Nearly 1000 respondents! Really great response to this survey. Please take the time to look at the link below if you haven’t already done so and help us get to 1000 #AMR #CF #COPD #PCD
Do you have a chronic lung condition? Take this survey to let us know your experience and understanding of antimicrobial resistance to help us to tackle it in the future. The survey takes about 15 minutes and is available in 20 languages. Find out more: europeanlung.org/en/get-involve…
Please take some time to help us understanding the effects of AMR in lung conditions @Amr_Lung
Do you have a chronic lung condition? Take this survey to let us know your experience and understanding of antimicrobial resistance to help us to tackle it in the future. The survey takes about 15 minutes and is available in 20 languages. Find out more: europeanlung.org/en/get-involve…
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics rdcu.be/dJTyk Miller & Arias explore recent advances in understanding ESKAPE pathogens, including epidemiology, clinical impact, resistance mechanisms and novel therapeutics.
Please support and help us better understand effects of #AMR in #lung disease @Amr_Lung @Freddy_Frost1 @Shoemelia @CtiaPaixao @AlibertiStefano @animeshraydoc @WorldBronch @BTSrespiratory @aluk_research
Do you have a chronic lung condition? Take this survey to let us know your experience and understanding of antimicrobial resistance to help us to tackle it in the future. The survey takes about 15 minutes and is available in 20 languages. Find out more: europeanlung.org/en/get-involve…
🎯 We're excited to announce that our diagnostic TPPs are now available! 🤝 With @NIHRTechEvalHRC we engaged with over 150 stakeholders to develop these TPPs. Request your copy & find out how you can work with us. ow.ly/nbXj50S7HjV @MedDiscCat | @cftrust | @lifearc1